PDS Biotechnology Corporation

PDSB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$26,199$31,873$39,979$41,690
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,694$1,775$2,490$3,365
Total Curr. Assets$27,893$33,648$42,469$45,054
Property Plant & Equip (Net)$259$0$289$304
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$6,554$6,828$4,271$0
Total NC Assets$6,813$6,828$4,560$304
Other Assets$0$0$0$0
Total Assets$34,706$40,476$47,029$45,359
Liabilities
Payables$5,181$4,497$2,859$1,685
Short-Term Debt$6,044$5,500$12,500$12,500
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$634$494$640$663
Total Curr. Liab.$13,329$11,531$18,265$17,087
LT Debt$11,889$12,944$6,352$9,205
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$11,923$12,985$6,401$9,267
Other Liabilities$0$0$0$0
Cap. Leases$77,659$93,110$108,211$123
Total Liabilities$25,252$24,516$24,666$26,354
Equity
Pref Stock$0$0$0$0
Common Stock$16$15$15$13
Retained Earnings-$209,044-$200,034-$190,600-$182,111
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity$9,454$15,960$22,362$19,005
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$34,706$40,476$47,029$45,359
Net Debt-$8,265-$13,430-$21,126-$19,985